Chemical Structure (Clorazepate 01)
Clorazepate Dipotassium Tablet
Product Images NDC 51672-4044
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Clorazepate Dipotassium (NDC 51672-4044). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Principal Display Panel (3.75 mg Bottle Label)
Principal Display Panel (15 mg Bottle Label)
Principal Display Panel (7.5 mg Bottle Label)
This is a medication called Clorazepate Dipotassium, which comes in a bottle of 100 tablets with 15 mg each. It is a prescription-only drug that requires dispensing the accompanying medication guide to each patient. The recommended dosage and precautions are available in the package insert. It should be stored at room temperature, protected from moisture in a tightly closed container. This medication is manufactured by Taro Pharmaceutical Industries Ltd, located in Haifa Bay, Israel, and distributed by Taro Pharmaceuticals U.S.A., Inc. The trademark registered for this medication is TARO. The second number provided is not clear and cannot be identified.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
